Within telehealth there are a number of domains relevant to pulmonary care: telemonitoring, teleassistance, telerehabilitation, teleconsultation and second opinion calls. In the last decade, several studies focusing on the effects of various telemanagement programs for patients with chronic obstructive pulmonary disease (COPD) have been published but with contradictory findings. From the literature, the best telemonitoring outcomes come from programs dedicated to aged and very sick patients, frequent exacerbators with multimorbidity and limited community support; programs using third-generation telemonitoring systems providing constant analytical and decisionmaking support (24 h/day, 7 days/week); countries where strong community links are not available; and zones where telemonitoring and rehabilitation can be delivered directly to the patient's location. In the near future, it is expected that telemedicine will produce changes in work practices, cultural attitudes and organization, which will affect all professional figures involved in the provision of care. The key to optimizing the use of telemonitoring is to correctly identify who the ideal candidates are, at what time they need it, and for how long. The time course of disease progression varies from patient to patient; hence identifying for each patient a 'correct window' for initiating telemonitoring could be the correct solution.
Introduction
Chronic obstructive pulmonary disease (COPD) is associated with a high cost burden. 1 Modern information communication technologies offer new options for delivering remote specialized healthcare, amongst which telemonitoring, a complex intervention that includes both the electronic transmission of patient information to the healthcare system and the follow-up response by a healthcare professional. Telehealth has been defined as the use of information and communication technologies (ICT) to deliver healthcare services and transmit medical data over long and short distances. 2 It encompasses a wide variety of technologies such as videoconferencing, internet platforms, store-and-forward devices, streaming media, and terrestrial and wireless communication. Telehealth may be used for a wide range of purposes: to decrease the demand on existing hospital and healthcare services; reduce the cost of care; measure treatment adherence; identify disease worsening; improve accessibility to services; and to extend the reach of services to remote locations. Telehealth is therefore a broad concept that involves diagnosis, treatment, monitoring, education and prevention. Within telehealth there are a number of domains relevant to pulmonary rehabilitation:
(1) Telemonitoring: the use of ICT to monitor patients at a distance. (2) Teleassistance: the provision of clinical care at a distance using ICT. (3) Telerehabilitation: the use of ICT to provide clinical rehabilitation services at a distance. 3 
Rationale for telehealth in COPD
The rationale for telemonitoring development in patients presenting with COPD with or without chronic respiratory failure is related to progressive aging of the patient population, carrying with it an increased burden of care at home; technological advances; increased healthcare consumption and the need to cut costs; difficulties associated with hospital discharge; early remote detection of signs and symptoms of COPD chronic respiratory insufficiency decompensation; 4 tailoring and monitoring at a distance of mechanical ventilation and providing education reinforcement for the patient and caregiver; and an opportunity to improve the access to pulmonary rehabilitation for aging populations in many developed countries and reduce patient-related barriers to attendance. 5 
Telehealth opportunities
There are several opportunities related to e-health: telemedicine (TM) with diagnosis at a distance based on spirometry tracing, teleconsultation, telemonitoring of biological signals, decision support systems, teletherapy, teleevaluation, telecare, telerehabilitation, telecoaching/mentoring, teleconference and second opinion calls. 6 The different generations of e-health, as thy have evolved, have proposed the following: measurements transferred to the care provider asynchronously (by store-and-forward protocols) (first generation); synchronized data transfer (automated algorithms can recognize important changes but delays can occur if the systems are not active 24 h/ day) (second generation); and constant analytical and decisionmaking support in which monitoring centers have full therapeutic authority 24 h/day, 7 days/week (third generation). The level of technology for an optimized e-health is available, but so far no one platform has proven its superiority over another. For this reason, the correct level of technology to use needs to be determined according to each individual patient, and it should be safe, feasible, effective, sustainable and flexible to the patient's condition.
Clinical findings
To date, the evidence as to whether telemonitoring is really effective in COPD seems inconclusive and contradictory. In the last decade, several studies have been published on the effects of various telemanagement programs for patients with COPD. Table 1 summarizes the RCTs on TM which showed positive results. Studies have been conducted in Europe (n = 18), the USA (n = 4), Australia (n = 1) and China/Taiwan (n = 2). A total of 4366 patients (mean age 71 ± 4 years) were studied with a mean forced expiratory volume in 1 s (FEV1) of 45 ± 10%; 12 ± 20% of the patients were on long-term oxygen therapy (LTOT), and all were frequent users of healthcare with a history of relapses and hospitalizations. In the majority of cases, the control groups were on the usual general practitioner (GP) care while the COPD groups were on a second-generation TM platform in 60% of cases and on a third-generation TM platform in 40% of cases for a mean time of 9 ± 7 months. Reduction in hospitalizations and use of other acute healthcare services, improvement in the quality of life and patient satisfaction were reported in the majority of studies providing chronic home care interventions and patient education at a distance (Table 1) . These programs were based on a strict adherence to care interventions to enhance symptom self monitoring by patients and their caregivers, through increasing their understanding of drug therapy, monitoring symptoms and treatment, and acting as a liaison between primary care providers and hospital services. This involved the delivery of time-intensive education by nurses and other personnel such as a respiratory therapist. [54] [55] [56] Table 2 [34] [35] [36] [37] [38] [39] [40] [41] [42] reports RCTs which showed contradictory results (both positive and negative according to the different outcomes). The studies were conducted in Europe (n = 5), the USA (n = 2) and Australia/New Zealand (n = 2). A journals.sagepub.com/home/tar 3 total of 1259 patients (mean age 68 ± 5 years) were studied with a mean FEV1 of 36 ± 8% and 42 ± 31% of cases were on LTOT; similarly to the positive studies, all patients with COPD were frequent users of healthcare and had a history of relapses and hospitalizations. Also in these studies, the control groups were mainly based on usual GP and home nurse care (sometimes with structured educational programs) while the studied groups were on second-generation TM platforms in 78% of cases and on third-generation TM platforms in 22% of cases for a mean time of 9 ± 7 months. Table 3 43-53 shows RCTs with negative results for TM use. These studies were conducted in Europe (n = 8), the USA (n = 2) and Australia (n = 1). A total of 5699 patients (mean age 69 ± 5 years) were studied with a mean FEV1 of 41 ± 4%, in 3 ± 8% of cases on LTOT, all frequent users of healthcare with a history of relapses and hospitalizations. The control groups were in the majority of cases based on usual GP care with stronger home care support (home visits, nurse availability, social services) compared with the positive studies. The experimental groups were on second-generation TM platforms in 73% of cases and on third-generation TM platforms in 27% of cases for a mean time of 8 ± 3 months.
The literature has shown that the best telemonitoring outcomes are expected in programs dedicated to aged and very sick patients with severe symptoms, frequent exacerbations, multimorbidity, on LTOT and with limited community support; long-term interventions; programs using third-generation telemonitoring systems providing constant analytical and decisionmaking support with monitoring centers led by a physician, staffed by specialist nurses, and have full therapeutic authority 24 h/day, 7 days/week; countries where home care is not widely available (if an extensive home care package with strong community links exists, telemonitoring may add little additional benefit); and zones where ICT and rehabilitation can be delivered directly to the patient's location, regardless of physical proximity to a rehabilitation center. Whilst only a few pulmonary rehabilitation programs worldwide are currently offering telerehabilitation, 57 this is likely to grow as telehealth applications become increasingly accessible to patients and clinicians.
Legal issues
The legal problems associated with teleassistance and TM are still controversial. Given that many processes of teleconsultation are patient specific and unique, the legal principles applying to conventional, face-to-face, doctor-patient relationships may be equally as valid in the context of the practice of medicine at a distance. 58, 59 Important system precautions need to be used by e-health users: 60, 61 (1) Data security and confidentiality. Suppliers and users must ensure the confidentiality, the authenticity of the data and their reporting, the authorized certification of procedures with digital signature, the protection of confidentiality, the security and privacy of the assisted persons, and the storage and transfer of sensitive data in real time between one unit and the other without manipulation. (2) Responsibilities and potential obligations of health professionals. Three key aspects need to be specified: the responsibility of the physician (teleconsultant) and the patient at distance (teleconsulted); the relationship and coresponsibility between specialist consultant and the requesting physician; the responsibility and the relationship between the applicant, consultant and service supplier or suppliers. (3) Interoperability. Mutual exchange of ICT-enabled solutions and of data are necessary for better coordination and integration across the entire chain of healthcare delivery to offer personalized solutions.
How will TM change clinical practice?
In the near future it is expected that TM will produce changes in work practices, cultural attitudes and organization, which need to be 'negotiated' among all the professional levels involved in the provision of care. Table 4 summarizes the possible change of scenarios in COPD care using TM. Table 5 summarizes barriers and difficulties to TM development in terms of work organization, cultural and technical concerns. [62] [63] [64] Discussion A 'one glove fits all' approach in offering telemonitoring for COPD appears too simplistic for a heterogeneous population such as these patients. Factors that will be important for the successful implementation of telemonitoring are an individually tailored approach, flexibility and a service that is locally responsive.
There are a number of possible explanations why the telemonitoring approach may not be superior to standard management carried out at home, which may be synthesized as follows:
( 65 In another study across the range of COPD severity, patients with severe COPD (GOLD 3 [Global Initiative for Chronic Obstructive Lung Disease] classification but not GOLD 4)and patients younger than 60 years are likely to be the most cost-effective group. 66 It is also common experience that, in patients with more severe disease, their clinical condition is such that hospital admissions are often inevitable: in any case, telemonitoring does not have the unique aim to avoid hospitalization per se but rather to control the progression of the disease, which sometimes will mean accelerating hospitalization, face-to-face visits or home care visits. Early treatment of home exacerbations at distance is often useful to prevent a catastrophic clinical worsening and subsequent need for intensive care unit admission or mechanical ventilation. (2) The use of different generations of the telemonitoring and e-health devices and platforms may have determined substantial differences in the findings across studies. Available telemonitoring devices range from basic first-generation systems to the far more complete third-generation systems. The role of the case manager/care manager during telemonitoring use may also vary among different countries depending on the current policy of each country's health system. (3) Previous results indicated that existing resource patterns of patients and variations in delivery-site practices might have a strong influence on cost effectiveness, possibly stronger than the included health or sociodemographic sources of heterogeneity. 66 To evaluate the real cost effectiveness of new methods such as telemonitoring in this population it is important to understand what is meant by 'standard care' and 'usual care' in the papers published so far. In fact, standard care varies greatly not only among European countries, but also within each country. 67 Some studies have also proposed health economic assessments 24,37,52 but the findings were inconclusive. Unfortunately, this 'standard' care is not a common or mandatory care approach in all European Union (EU) countries. If an extensive home care package with strong community links exists, telemonitoring may add little additional benefit, whereas for trials in which less community support was available telemonitoring seems to show more benefit in terms of team expertise and the patient's (or carer's) self efficacy. (4) Now, the question to evaluate is if the superiority of telemonitoring to the gold standard is really the goal. Equivalence between telemonitoring and the gold standard may be a more appropriate goal; indeed, an intervention that cost-effectively Last but not least, negative or positive results clearly depend on the expected outcomes of the study (e.g. healthcare use, patient-related outcomes, adherence, mechanical ventilation initiation and adaptation, need for palliative care) and corresponding methodological development, which differ from one study to the next.
As shown in Table 5 62-64 major barriers for TM implementation are lack of awareness/confidence in e-health, supposed e-health complexity and time consumption during the working day, necessity for complicated medical licensing, the risk for doctors to reduce the area of influence with a decreased chain of command, more cooperation requested between primary and secondary healthcare, risk of data protection and privacy, lack of structured best practices, solid public or private providers and dedicated call centers, the necessity for infrastructure accreditation with certification and labelling obstacles, and last but not least, regional differences in accessing ICT services.
Future directions
Another important aspect in telemonitoring studies is using advanced analytics or machine learning to optimize the patient's condition, for example by early identification of COPD exacerbations. This is going to be an important future direction and challenge in patients with COPD breathing spontaneously. [68] [69] [70] The 24 and patients are enthusiastic about this service. 73 Anyway, the patient's perspective is not always the doctor's perspective: in a recent survey 74 about 50% of patients receiving home mechanical ventilation responded that they would refuse telemonitoring because it feels like 'big brother', and expressed concerns about privacy of personal information/data. They also felt it might increase anxiety as a result of fewer visits and fewer opportunities to enjoy personal contact, and finally that their actual home care settings 'feels good and they don't want it adjusted'.
Home telemonitoring and telerehabilitation of chronic diseases seems to be a promising patient management strategy that could produce accurate and reliable data, empower patients, influence their attitudes and behavior, and potentially improve their medical conditions. Remote monitoring alone is not sufficient for successful disease management. A patient-centered design approach (continuous improvement allowed feedback from users) has been used in order to allow the personalization of interventions and encourage the completion of daily self-management tasks resulting in high compliance with self monitoring over a prolonged period of time (12 months). 75 The overall body of literature on this topic shows that the extent and significance of benefits to patients and economic organizational expectations are not always consistent and sometimes remain inconclusive. The impact on clinical effectiveness outcomes and economic viability likewise remains unclear. At the moment the fundamental prerequisite for the efficacy of telemonitoring in COPD management is to establish common standardized protocols rather than determine how to deliver the care. 76 It is clear that telemonitoring alone is not sufficient in itself to yield a better outcome; telemonitoring could be a key element in the management of COPD, but it is difficult to evaluate its benefit without considering the other services received by patients (GP network, home care, access to hospital, social care). Considering the overall care 'package' received by the patient, telemonitoring may have a place as one of the services offered within the package. But other aspects, quality improvement, integration of programs and services, increase in collaboration and communication across the different care settings, and the development of a shared vision, goals and priorities, are needed to improve the efficiency of the healthcare services provided for patients with chronic disease. 76 The key point in optimizing the use of telemonitoring is to correctly identify who the ideal candidates are, and at what time they should receive it and for how long. 76 The time course of disease for each patient is different and a 'correct window' for personalized TM application could be the answer. Initiating a TM program too early might be useless and inefficient, while only the TM program in very advanced conditions might be insufficient due to the high level of disability and instability which cannot be completely managed and monitored at a distance.
In conclusion, TM will provide a framework for patient engagement and a new model of care delivery utilizing integrated practice units, both of which are needed to navigate the healthcare needs of the 21st century. As clinicians we need to identify the specific challenges we face in delivering care changing our future clinical practice implementing flexible systems that can be customized to individual patients' requirements and adapted to our diverse healthcare contexts. 
